-
The growth round will accelerate the expansion of Recare’s AI platform, reducing administrative workload for medical and nursing staff through automated documentation and process control.
-
DNV becomes the largest shareholder in Recare, with additional participation from CIBC Innovation Banking.
-
The partnership supports Recare’s international expansion and strengthens DNV’s presence in the German healthcare market.
Berlin, 29 January 2026 – Recare, a Berlin-based provider of technology solutions for hospitals and care providers, has closed a growth financing round up to 37 million euros, including a 7 million euro option. The financing round has been led by DNV, the independent assurance and risk management provider, with additional participation from CIBC Innovation
Banking and other investors. It makes DNV the largest shareholder in Recare.
Founded in 2017, Recare provides two-thirds of German hospitals and more than 26,000 care providers with a software-as-a-service platform that digitally simplifies discharge management and aftercare. The new capital from the funding round will fast-track the introduction of a new AI agent to hospitals and care facilities and expand the company’s international business.
Recare’s AI agent enables care providers to improve automation of administrative tasks and coordinate workflows to reduce the workload of healthcare professionals at a time of growing skills shortages in the sector. The European Commission has estimated that Europe already faces a shortage of approximately one million doctors and nurses. This gap is projected to worsen significantly by 2030.
“Hospitals are under enormous operational pressure, as healthcare professionals spend increasing time on administrative tasks—leaving less capacity for what matters most: caring for patients. Recare’s AI agent platform relieves a large part of this administrative burden by leveraging unstructured data to rapidly orchestrate workflows. The new investment into our business will accelerate the roll-out of our AI agent across Germany and abroad, helping healthcare providers to transform their workforce capacity,” said Maximilian Greschke, CEO of Recare.
The AI agent acts as a smart hub that connects existing hospital IT systems. It intelligently coordinates clinical and administrative workflows across departments, automates documentation and routine tasks including medical letters and handover protocols, and automatically extracts and structures data from PDFs, scans, and free text into interoperable formats. This breaks down data silos and helps workflows run smoothly end-to-end.
“Recare is proving that smarter workflows translate into measurable productivity for German healthcare. DNV’s investment will scale that impact internationally. Recare’s market leadership and ambitious AI plans fit perfectly with DNV’s focus on solutions that raise efficiency and reliability through secure, accurate, interoperable data,” said Daniel Holth Larsen, Managing Director, Digital Health, DNV.
DNV has served the healthcare sector for nearly four decades, building trust across the value chain in many countries. The investment in Recare expands the company’s growing portfolio of digital health companies, which includes real-time data integration tool provider DNV Imatis, healthcare productivity and data assurance specialist MBI Health, and Patients Know Best, a leader in patient-controlled health records.
Charlotte Goggin, Director, CIBC Innovation Banking, said: “We are pleased to support Recare as part of its latest funding round. For healthcare institutions, administrative tasks are time-consuming and take away from valuable hours that could be spent helping patients. Recare addresses this with its platform that maximises optionality for patients requiring aftercare solutions and streamlines the discharge and after-care processes.”
For further information visit: www.recaresolutions.com
